What happened
Hwail Pharm's controlling stake is set to change hands from Osung Advanced Materials and 1 other to Pharma & Bio New Technology Partnership, in a deal worth US$55M.
A change of the controlling shareholder can reshape a company's strategy, capital allocation, and board.
| From | Osung Advanced Materials and 1 other |
|---|---|
| To | Pharma & Bio New Technology Partnership |
| Deal value | US$55M |
| Filed | 2026-09-15, Share transfer agreement that will change the largest shareholder |
| Source | DART rcept 20260915900712 → open original filing |
Source: DART. Information only, not investment advice.